Actual Medicinal Product (AMP) Losartan 100mg / Hydrochlorothiazide 25mg tablets (Alliance Healthcare (Distribution) Ltd)
Stability Information
(Some stability information inherited from generic)
- Stability
-
Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
Light sensitive medicine. Store in light resistant container. Moisture sensitive medicine. Store in airtight (sealed) MCA Manufacturer recommends storing in original container.
No stability data in MCAs available. - Provenance
-
This recommendation is based on the products COZAAR-COMP 100mg/25mg tablets (Organon Pharma (UK) Limited) and losartan potassium/hydrochlorothiazide 100mg/25mg tablets (Krka UK Ltd).
- Generic
- Losartan + Hydrochlorothiazide
- Formulation
- Losartan 100mg / Hydrochlorothiazide 25mg tablets
-
Losartan + Hydrochlorothiazide
-
Losartan 100mg / Hydrochlorothiazide 25mg tablets
-
Losartan 100mg / Hydrochlorothiazide 25mg tablets (Alliance Healthcare (Distribution) Ltd)
-
-